Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 124.60
Bid: 124.60
Ask: 125.00
Change: 1.20 (0.97%)
Spread: 0.40 (0.321%)
Open: 123.20
High: 124.80
Low: 123.20
Prev. Close: 123.40
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value

30 Apr 2024 07:00

RNS Number : 4884M
HICL Infrastructure PLC
30 April 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

This announcement has been determined to contain inside information for the purposes of the market abuse regulation (EU) No.596/2014.

30 April 2024

 

HICL Infrastructure PLC

 

"HICL" or the "Company" and, together with its corporate subsidiaries1, the "Group", the London-listed infrastructure investment company managed by InfraRed Capital Partners Limited ("InfraRed" or the "Investment Manager").

Net Asset Value

The Company's Annual Results are scheduled for release on 22 May 2024.

The Board expects to announce a decrease in the Company's unaudited Net Asset Value ("NAV") per share of approximately 1.2 pence to 158.2 pence as at 31 March 2024 (30 September 2023: 159.4 pence). This statement explains the Company's approach to determining the NAV as at 31 March 2024.

The expected NAV decrease is mainly driven by the following macroeconomic factors:

· Actual inflation for the year to March 2024 being lower than the assumptions used in the portfolio valuation as at 30 September 2023;

· A reduction in UK inflation assumptions for FY2025 and FY2026, aligning with market consensus;

· A reduction in deposit rate assumptions for all jurisdictions except the USA, aligning with market consensus; and

· Adverse foreign exchange movements as sterling strengthened in the period, net of hedging.

Operational performance of the portfolio was broadly in line with expectations. During the second half of its financial year, the Company disposed of its remaining interest in the Northwest Parkway toll road project in the USA. The proceeds received represented a premium to the Company's September 2023 valuation of 30% / 2.1 pence. The acquisition of a 3.1% incremental interest in the A63 Motorway concession generated 0.7 pence as it was revalued to HICL's existing holding. These two items partially offset the reduction caused by the macroeconomic factors outlined above.

Breakdown of the movement in Net Asset Value per share

Net Asset Value per share as at 30 September 2023 (unaudited)

159.4p

Portfolio return

Actual inflation

(2.0)

Other portfolio performance2

8.8

 

6.8

 

Discount rate

-

 

Macroeconomic assumptions

Forecast inflation

(1.3)

Interest rates

(0.5)

 

(1.8)

 

Fund and interest costs

(1.8)

Foreign exchange (net of hedging)

(0.3)

Dividends paid

(4.1)

Net Asset Value per share as at 31 March 2024 (unaudited)

158.2p

Inflation

The portfolio's cashflows and valuation are positively correlated to inflation. Over the past six months, inflation in all regions has declined faster than the Company's forecast, particularly in the UK where RPI reduced to 4.0% for the year ended 31 March 2024 (2023: 13.9%) against the Company's forecast of 6.5%.

Other jurisdictions also saw accelerated inflation reductions. French CPI was 2.3% (2023: 5.7%), while in the USA CPI was 3.0% (2023: 5.0%). The impact of the decrease in actual inflation versus forecast assumptions resulted in a valuation downside of £(24.3)m in the six-month period.

In the short to medium term, market consensus is that UK inflation is expected to decline further; and adjustments have now been made to the Company's short-term UK inflation assumptions for FY2025 and FY2026 to reflect the steeper decline in inflation than originally expected. No changes have been made to UK inflation assumptions post-2026, nor to inflation assumptions in other jurisdictions. 

Discount rates

Long-term government bond yields have reduced in all relevant jurisdictions since the Company's 30 September 2023 valuation. While discount rates used to value investments do not follow bond yields exactly, the Investment Manager considers the level of risk premium implied by movements in bond yields, as well as evidence of asset pricing observed in core infrastructure transactions across HICL's key geographies. This includes the ten divestments made by HICL over the course of the year.

Although there is increasing market confidence that interest rates may have peaked in the UK, the Investment Manager believes that the increase in discount rates, recognised in the 30 September 2023 valuation, remains appropriate for the 31 March 2024 valuation and continues to be in line with external transaction data points. This assessment is underpinned by the material level of transaction activity completed by the Company over the last twelve months.

The weighted average discount rate remains at 8.0%, the weighted average risk-free rate for the portfolio is 4.1% (30 September 2023: 4.7%) and the weighted average risk premium is 3.9% (30 September 2023: 3.3%).

InfraRed will continue to closely monitor market activity and will provide a further update, as appropriate, as part of HICL's Annual Results on 22 May 2024.

Foreign Exchange

The Company is exposed to movements in the Canadian dollar, the Euro, the New Zealand dollar and the US dollar; but with 61% of the Company's exposure to foreign currency hedged as at 31 March 2024, there was only a small valuation loss over the period. 

Funding position

At 31 March 2024 the Group had net debt of £303.9m (30 September 2023: £496.8m), comprising cash of c. £33.3m, drawings on the Revolving Credit Facility ("RCF") of c. £187.2m and the private placement of £150.0m. As at 31 March 2024, the sales of Northwest Parkway and Hornsea II OFTO had signed but not yet completed. Northwest Parkway completed on 18 April 2024 and the Hornsea II OFTO is expected to complete in May 2024. Following these, the pro forma drawings on the RCF are expected to be nil and gearing is expected to be 7%.

Macroeconomic assumptions used in the valuation

Assumption

Jurisdiction

31 March 2024

30 September 2023

Discount rate (WADR)

8.0%

8.0%

Inflation

UK (RPI and RPIx)

3.00% to 31-Mar-25

2.75% to 31-Mar-26

3.25% to 31-Mar-30

2.50% thereafter

6.50% to 31-Mar-24

3.50% to 31-Mar-25

3.25% to 31-Mar-30

2.50% thereafter

UK (CPI/CPIH)

2.25% to 31-Mar-25

2.00% to 31-Mar-26

2.50% thereafter

5.75% to 31-Mar-24

2.75% to 31-Mar-25

2.50% thereafter

Eurozone (CPI)

2.25% to 31-Mar-25

2.00% thereafter

4.75% to 31-Mar-24

2.25% to 31-Mar-25

2.00% thereafter

Canada (CPI)

2.25% to 31-Mar-25

2.00% thereafter

3.00% to 31-Mar-24

2.25% to 31-Mar-25

2.00% thereafter

US (CPI)

2.00% to 31-Mar-25

2.00% thereafter

3.00% to 31-Mar-24

2.00% thereafter

New Zealand

2.75% to 31-Mar-25

2.25% thereafter

5.00% to 31-Mar-24

2.75% to 31-Mar-25

2.25% thereafter

Deposit rates

UK

4.50% to 31-Mar-25

3.25% thereafter

5.00% to 31-Mar-24

4.50% to 31-Mar-25,

3.50% thereafter

Eurozone

3.00% to 31-Mar-25

2.00% thereafter

3.00% to 31-Mar-25,

2.25% thereafter

Canada

3.75% to 31-Mar-25

3.00% thereafter

3.75% to 31-Mar-25

3.25% thereafter

US

4.25% to 31-Mar-25

3.25% thereafter

4.25% to 31-Mar-25

3.25% thereafter

New Zealand

4.25% to 31-Mar-25

4.00% thereafter

4.50% to 31-Mar-24

4.25% thereafter

Foreign exchange rates

USD

1.26

1.22

EUR

1.17

1.15

CAD

1.71

1.66

NZD

2.11

2.03

 

1. The Corporate subsidiaries are Infrastructure Investments Limited Partnership and HICL Infrastructure 2 s.a.r.l., as disclosed in HICL's Annual Report and Accounts 2023

2. Performance comprises the unwinding of the discount rate (value preservation), the Investment Manager's value enhancement initiatives and accretive transaction activity

 

-ends-

 

Enquiries

InfraRed Capital Partners Limited +44 (0) 20 7484 1800 / info@hicl.com

Edward Hunt

Helen Price

Mohammed Zaheer

 

Brunswick Group Advisory Ltd +44 (0) 20 7404 5959 / HICL@brunswickgroup.com

Sofie Brewis

 

Investec Bank plc +44 (0) 20 7597 4952

David Yovichic

 

RBC Capital Markets +44 (0) 20 7653 4000

Matthew Coakes

Elizabeth Evans

 

Aztec Financial Services (UK) Limited +44 (0) 203 818 0246

Chris Copperwaite

Sarah Felmingham

 

HICL Infrastructure PLC

HICL Infrastructure PLC ("HICL") is a long-term investor in infrastructure assets which are predominantly operational and yielding steady returns. It was the first infrastructure investment company to be listed on the London Stock Exchange.

With a current portfolio of over 100 infrastructure investments, HICL is seeking further suitable opportunities in core infrastructure, which are inherently positioned at the lower end of the risk spectrum.

Further details can be found on the HICL website www.hicl.com.

This statement aims to give an indication of material events and transactions that have taken place in the period from 1 October 2023 to 31 March 2024 and their impact on the financial position of HICL. These indications reflect the Board's current view. They are subject to several risks and uncertainties and could change. Factors which could cause or contribute to such differences include, but are not limited to, general economic and market conditions and specific factors affecting the financial prospects or performance of individual investments within the portfolio of HICL.

Investment Manager (InfraRed Capital Partners)

The Investment Manager to HICL is InfraRed Capital Partners Limited ("InfraRed") which has successfully invested in infrastructure projects since 1997. InfraRed is a leading international investment manager, operating worldwide from offices in London, New York, Seoul, Madrid and Sydney and managing equity capital in multiple private and listed funds, primarily for institutional investors across the globe. InfraRed is authorised and regulated by the Financial Conduct Authority.

The infrastructure investment team at InfraRed consists of over 100 investment professionals, all with an infrastructure investment background and a broad range of relevant skills, including private equity, structured finance, construction, renewable energy and facilities management.

InfraRed implements best-in-class practices to underpin asset management and investment decisions, promotes ethical behaviour and has established community engagement initiatives to support good causes in the wider community. InfraRed is a signatory of the Principles of Responsible Investment.

Further details can be found on InfraRed's website www.ircp.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVFLFLTSLIAFIS
Date   Source Headline
26th Sep 20172:30 pmRNSAdditional Listing
14th Sep 20175:31 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSCompletion of Acquisition
1st Sep 20172:11 pmRNSScrip Share Reference Price
26th Jul 20178:25 amRNSPreferred Bidder Announcement
24th Jul 20177:00 amRNSInterim Update Statement
21st Jul 20173:00 pmRNSScrip Dividend Circular
18th Jul 20173:33 pmRNSFirst Quarterly Interim Dividend
14th Jul 20172:50 pmRNSAcquisition
5th Jul 20173:40 pmRNSDirector/PDMR Shareholding
3rd Jul 20175:38 pmRNSTotal Voting Rights
22nd Jun 20172:00 pmRNSAdditional Listing
13th Jun 20178:44 amRNSAnnual General Meeting Circular
13th Jun 20177:00 amRNSAnnual General Meeting Circular
13th Jun 20177:00 amRNSAnnual Financial Report
5th Jun 20173:22 pmRNSResult of Equity Issue
2nd Jun 20171:24 pmRNSScrip Share Reference Price
24th May 20177:00 amRNSAnnual Results for the year ended 31 March 2017
24th May 20177:00 amRNSIssue of Equity
22nd May 20177:00 amRNSCompletion of Acquisition
18th May 201711:21 amRNSFourth Quarterly Interim Dividend
2nd May 20177:00 amRNSAcquisition of a new investment
2nd May 20177:00 amRNSIncrease in the Group's credit facility
10th Apr 20177:00 amRNSNotice of Annual Results
5th Apr 20174:00 pmRNSDirector/PDMR Shareholding
4th Apr 201710:28 amRNSHolding(s) in Company
3rd Apr 20178:00 amRNSIncremental Investment
31st Mar 20175:11 pmRNSTotal Voting Rights
29th Mar 20174:00 pmRNSDirector/PDMR Shareholding
24th Mar 20178:00 amRNSAdditional Listing and Total Voting Rights
22nd Mar 20174:00 pmRNSDirector/PDMR Shareholding
22nd Mar 201710:16 amRNSAdditional Listing
22nd Mar 20177:00 amRNSResult of Equity Issue
21st Mar 20179:28 amRNSTerms and Conditions of the Placing
20th Mar 201711:49 amRNSDirectorate Change
20th Mar 201711:36 amRNSResults of EGM
10th Mar 20178:00 amRNSCompletion of Acquisition
9th Mar 20172:37 pmRNSScrip Share Reference Price
23rd Feb 20175:41 pmRNSPublication of a Prospectus and Circular
23rd Feb 20175:00 pmRNSPublication of a Prospectus and Circular
22nd Feb 20174:45 pmRNSThird Quarterly Interim Dividend
2nd Feb 201711:44 amRNSInterim Update Statement February 2017
23rd Jan 20177:00 amRNSCompletion of Acquisition
12th Jan 20172:42 pmRNSIntention to issue new equity
5th Jan 20177:00 amRNSCompletion of Two Acquisitions
4th Jan 20174:00 pmRNSDirector/PDMR Shareholding
30th Dec 20164:00 pmRNSTotal Voting Rights
16th Dec 201612:32 pmRNSAdditional Listing
7th Dec 20163:45 pmRNSDirector/PDMR Shareholding
2nd Dec 201610:00 amRNSDirector Declaration - Additional Directorship

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.